Research Topics
| Ulrich Frank PapeSummaryAffiliation: Humboldt University Country: Germany Publications
| Collaborators
|
Detail Information
Publications
Prognostic factors of long-term outcome in gastroenteropancreatic neuroendocrine tumoursUlrich Frank Pape
Department of Hepatology and Gastroenterology, Charite, Campus Virchow Klinikum, University Medicine Berlin, Berlin, Germany
Endocr Relat Cancer 15:1083-97. 2008....
Survival and clinical outcome of patients with neuroendocrine tumors of the gastroenteropancreatic tract in a german referral centerUlrich Frank Pape
Department of Internal Medicine, Charite Universitatsmedizin Berlin, Campus Virchow Klinikum, Medical Faculty of the Humboldt University, Berlin, Germany
Ann N Y Acad Sci 1014:222-33. 2004..7% of successfully resected patients. Palliative medical treatment, either with chemotherapy (i.e., especially for foregut NETs) or biotherapy (especially for midgut NETs), was only moderately effective for both therapeutic regimens...- Prognostic relevance of a novel TNM classification system for upper gastroenteropancreatic neuroendocrine tumorsUlrich Frank Pape
Department of Hepatology and Gastroenterology, Chariteé Campus Virchow Clinic, Berlin University of Medicine, Berlin, Germany
Cancer 113:256-65. 2008..In 2006, a new TNM classification system was proposed for the staging and grading of upper GEP NETs... - Cost comparison of 111In-DTPA-octreotide scintigraphy and 68Ga-DOTATOC PET/CT for staging enteropancreatic neuroendocrine tumoursNils F Schreiter
Department of Nuclear Medicine, Charite Universitatsmedizin Berlin, Berlin, Germany
Eur J Nucl Med Mol Imaging 39:72-82. 2012..The aim of this study was to compare the costs for the two diagnostic tests and the respective consequential costs... - Neuroendocrine tumors of midgut and hindgut origin: tumor-node-metastasis classification determines clinical outcomeHenning Jann
Department of Hepatology and Gastroenterology, Charite, Campus Virchow Klinikum, University Medicine Berlin, Berlin, Germany
Cancer 117:3332-41. 2011..The purpose of this study was to test the efficacy of a proposal for TNM staging and grading for midgut and hindgut NETs... - From basic to clinical research in gastroenteropancreatic neuroendocrine tumor disease -- the clinician-scientist perspectiveBertram Wiedenmann
Department of Internal Medicine, Division of Hepatology and Gastroenterology, Interdisciplinary Center of Metabolism and Endocrinology, Charite, Campus Virchow Hospital, University Medicine Berlin, Berlin, Germany
Neuroendocrinology 80:94-8. 2004..As well, new therapeutic treatment options translated from current findings in the fields of molecular and tumor biology are discussed... - Impact of Ga-68 DOTATOC PET/CT on the diagnosis and treatment of patients with multiple endocrine neoplasiaVera Froeling
Department of Radiology, Charite, Universitatsmedizin Berlin, Campus Virchow Klinikum, Augustenburger Platz 1, 13353, Berlin, Germany
Ann Nucl Med 26:738-43. 2012..To evaluate the impact of Ga-68 DOTATOC PET/CT on diagnosis and therapeutic management of patients with multiple endocrine neoplasia (MEN)... - Evaluation of the potential of PET-MRI fusion for detection of liver metastases in patients with neuroendocrine tumoursNils F Schreiter
Department of Nuclear Medicine, Charite, Augustenburger Platz 1, 13353 Berlin, Germany
Eur Radiol 22:458-67. 2012..This study was performed to assess the role of retrospective PET-MRI fusion with Ga-68-DOTA(0)-Phe(1)-Tyr(3)-octreotide (Ga-68-DOTATOC) PET and Gd-EOB-DTPA MRI in the detection of hepatic metastases from neuroendocrine tumours (NET)... - Magnetic resonance enteroclysis in patients with Crohn's disease: fat saturated T2-weighted sequences for evaluation of inflammatory activityChristian Grieser
Klinik für Radiologie, Campus Virchow Klinikum, Charite Universitatsmedizin Berlin, Augustenburger Platz 1, 13353 Berlin, Germany
J Crohns Colitis 6:294-301. 2012..To evaluate fat saturated (fs) T2-weighted (w) fast relaxation fast spin echo (FRFSE)-sequences compared to the standard protocol with contrast agent for the evaluation of inflammatory activity in patients with Crohn's Disease (CD)... - Influence of attenuation correction by integrated low-dose CT on somatostatin receptor SPECTJuri Ruf
Klinik fur Strahlenheilkunde, Charite, Centrum 6 für diagnostische und interventionelle Radiologie und Nuklearmedizin, Charite Universitatsmedizin Berlin, Germany
Nucl Med Commun 28:782-8. 2007..Somatostatin receptor scintigraphy (SRS) is well-established in neuroendocrine tumour (NET) imaging. This study evaluated the impact of attenuation correction (AC) on SRS SPECT data in patients examined by SPECT-CT... - Placebo-controlled, double-blind, prospective, randomized study on the effect of octreotide LAR in the control of tumor growth in patients with metastatic neuroendocrine midgut tumors: a report from the PROMID Study GroupAnja Rinke
Department of Internal Medicine, Division of Gastroenterology and Endocrinology, Institute of Medical Biometry and Epidemiology, Philipps University, Marburg, Germany
J Clin Oncol 27:4656-63. 2009..We performed a placebo-controlled, double-blind, phase IIIB study in patients with well-differentiated metastatic midgut NETs. The hypothesis was that octreotide LAR prolongs time to tumor progression and survival... - Prospective, randomized, multicenter trial on the antiproliferative effect of lanreotide, interferon alfa, and their combination for therapy of metastatic neuroendocrine gastroenteropancreatic tumors--the International Lanreotide and Interferon Alfa StudySiegbert Faiss
, Campus Virchow Klinikum, Medizinische Klinik mit Schwerpunkt Hepatologie und Gastroenterologie, Augustenburger Platz 1, D-13353 Berlin, Germany
J Clin Oncol 21:2689-96. 2003..Response rates were lower compared with those published in previous, nonrandomized studies. The antiproliferative effect of the tested substances was similar for functional and nonfunctional neuroendocrine tumors...